跳至主要内容
临床试验/NCT07137234
NCT07137234已完成不适用

Efficacy of Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy: A Randomized Controlled Clinical Trial.

Mansoura University1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年3月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
Scar width

研究概览

简要总结

the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Weeks 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients with mild to severe unilateral cleft lip requiring repair
  • •free from any systemic disease
  • •with or without cleft palate
  • •fit for general anesthesia

排除标准

  • •patients with syndromic type of cleft lip
  • •patients with systemic disease

研究组 & 干预措施

Group I : 16 patient with unilateral cleft lip treated with surgical procedure alone

Experimental

干预措施: Modified Millard rotation advancement flap technique (Procedure)

Group II : 16 patients with unilateral cleft lip treated with botulinum toxin injection and surgery

Experimental

干预措施: Modified Millard rotation advancement flap technique (Procedure)

Group II : 16 patients with unilateral cleft lip treated with botulinum toxin injection and surgery

Experimental

干预措施: botulinum toxin injection (BTX A) before surgical intervention (Drug)

结局指标

主要结局

Scar width

时间窗: 3 and 6 months follow up

Scar width will be measured by independent examiners at two at two certain points using caliper: point 1 (Bottom) :above the white roll. point 2 (Top): below the nasal sill.

次要结局

  • Vancouver scar scale(3 and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Basel Saeed Sayed Ahmed Shamaa

Clinical Demonstrator at oral and maxillofacial surgery department, Faculty of dentistry, Mansoura University

Mansoura University

研究点 (1)

Loading locations...

相似试验